BioVie Inc. Form CERT: Certification of approval for listing
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2025-08-07: Form CERT; Description Certification of approval for listing; Document BIVIW_8-A_Cert.pdf.
- 2020-09-17: Form CERT; Description Certification of approval for listing; Document 8A_Cert_BIVI_3.pdf.
- 2019-10-18: Form CERT; Description Certification of approval for listing; Document 8A_Cert_BIVI_2.pdf.
- 2019-08-12: Form CERT; Description Certification of approval for listing; Document 8A_Cert_BIVI.pdf.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2025-08-07 | CERT | Certification of approval for listing | BIVIW_8-A_Cert.pdf | |
| 2020-09-17 | CERT | Certification of approval for listing | 8A_Cert_BIVI_3.pdf | |
| 2019-10-18 | CERT | Certification of approval for listing | 8A_Cert_BIVI_2.pdf | |
| 2019-08-12 | CERT | Certification of approval for listing | 8A_Cert_BIVI.pdf |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |